Evidence map›Paper›PMID 22645023›Full record

Trial reportAge (Dordrecht, Netherlands)2013

Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects.

Marco Antonio Moro-García, Rebeca Alonso-Arias, Maria Baltadjieva, Carlos Fernández Benítez, Manuel Amadeo Fernández Barrial, Enrique Díaz Ruisánchez, Ricardo Alonso Santos, Magdalena Alvarez Sánchez, Juan Saavedra Miján, Carlos López-Larrea

3 registry-linked trialsOpen access · greenAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Age (Dordrecht, Netherlands), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 59 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 4 pooled it
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07439978 phase1not yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Physiological Study of a Fermented Yogurt Drink Containing Probiotics

TypeinterventionalSponsorUniversity College DublinRan2026 to 2026Enrolled50ConditionsColonization, Asymptomatic, ColonisationArmsprobiotic containing L.rhamnosus R0011 strain, 200 ml yogurt drink
NCT07510282 phase1not yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Physiological Study on How Probiotic Delivered to the Small Intestine Changes Microbiota

TypeinterventionalSponsorUniversity College DublinRan2026 to 2026Enrolled25ConditionsColonization, Asymptomatic, ColonizationArmsProbiotic containing L.rhamnosus R0011 strain, 200 ml yogurt drink
NCT07679490 naactive not recruitingnot on this mapstarted 2026, after this paper: background citation

A Physiological Study of a Fruit Snack Containing Probiotics

TypeinterventionalSponsorUniversity College DublinRan2026 to 2027Enrolled25ConditionsColonization, Asymptomatic, Probiotic Intervention, Gut Microbiota Diversity and Composition, Gut-brain AxisArmsMicroencapsulated Lactobacillus rhamnosus Fruit Snack, Placebo Fruit Snack
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 4 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Review
  13. Review
  14. Immunological biomarkers of aging.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Review
  15. Article
  16. Review
  17. Antioxidants (Basel, Switzerland) · 2024
    Article
  18. Review
  19. Article
  20. The Efficacy ofMetabolites · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Marco Antonio Moro-GarcíaImmunology Department, Hospital Universitario Central de Asturias, 33006, Oviedo, Spain.
Rebeca Alonso-Arias
Maria Baltadjieva
Carlos Fernández Benítez
Manuel Amadeo Fernández Barrial
Enrique Díaz Ruisánchez
Ricardo Alonso Santos
Magdalena Alvarez Sánchez
Juan Saavedra Miján
Carlos López-Larrea
Hospital Universitario Central de Asturias · ESFood Research and Development Institute · BGServicio Cántabro de Salud · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Throughout life, there is an aging of the immune system that causes impairment of its defense capability. Prevention or delay of this deterioration is considered crucial to maintain general health and increase longevity. We evaluated whether dietary supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 could enhance the immune response in the elderly. This multi-center, double-blind, and placebo controlled study enrolled 61 elderly volunteers who were randomly assigned to receive either placebo or probiotics. Each capsule of probiotics contained at least 3 × 10(7)  L. delbrueckii subsp. bulgaricus 8481. Individuals in the study were administered three capsules per day for 6 months. Blood samples were obtained at baseline (time 0), end of month 3, and month 6. We characterized cell subpopulations, measured cytokines by flow cytometry, quantified T cell receptor excision circle (TREC) by real-time PCR (RT-PCR), and determined human β-defensin-2 (hBD-2) concentrations and human cytomegalovirus (CMV) titers by enzyme-linked immunosorbent assay (ELISA). Elderly responded to the intake of probiotic with an increase in the percentage of NK cells, an improvement in the parameters defining the immune risk profile (IRP), and an increase in the T cell subsets that are less differentiated. The probiotic group also showed decreased concentrations of the pro-inflammatory cytokine IL-8 but increased antimicrobial peptide hBD-2. These effects disappeared within 6 months of stopping the probiotic intake. Immunomodulation induced by L. delbrueckii subsp. bulgaricus 8481 could favor the maintenance of an adequate immune response, mainly by slowing the aging of the T cell subpopulations and increasing the number of immature T cells which are potential responders to new antigens.

Indexed as

Lactobacillus delbrueckiiAgedAged, 80 and overAgingbeta-DefensinsDNADouble-Blind MethodEnzyme-Linked Immunosorbent AssayFemaleFollow-Up StudiesGene Expression RegulationHumansImmunity, CellularInterleukin-8MaleProbioticsbeta-DefensinsDEFB4A protein, humanDNAInterleukin-8

Identifiers

PMID22645023
PMCPMC3705123
OpenAlexW2071483954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.